Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three small molecule drugs—ibuprofen, ondansetron, and misoprostol—used adjunctively in the context of medication abortion or for managing pain and gastrointestinal side effects associated with uterine procedures. - **Ibuprofen** is a nonsteroidal anti-inflammatory drug (NSAID) that acts as an analgesic and antipyretic by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing prostaglandin synthesis involved in pain, inflammation, and fever. - **Ondansetron** is a selective serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting by blocking serotonin receptors centrally in the chemoreceptor trigger zone and peripherally on vagal nerve terminals. - **Misoprostol** is a synthetic prostaglandin E1 analog that binds to prostaglandin E1 receptors on gastric parietal cells to reduce acid secretion, increase mucus/bicarbonate production for mucosal protection, and stimulate uterine contractions by binding smooth muscle cells in the uterus. In clinical practice, this combination is not available as a single commercial product but may be prescribed together during medication abortion regimens (with mifepristone) to manage cramping (ibuprofen), prevent or treat nausea/vomiting (ondansetron), and induce uterine contractions/expulsion of pregnancy tissue (misoprostol)[1][3][7][8]. Each component has distinct mechanisms but complementary roles in improving patient comfort during medical abortion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ibuprofen + ondansetron + misoprostol.